2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Autoimmune Diabetes in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyun, E | 1 |
| Ramachandran, R | 1 |
| Cenac, N | 1 |
| Houle, S | 1 |
| Rousset, P | 1 |
| Saxena, A | 1 |
| Liblau, RS | 1 |
| Hollenberg, MD | 1 |
| Vergnolle, N | 1 |
| Lin, HY | 1 |
| Tsai, CC | 1 |
| Chen, LL | 1 |
| Chiou, SH | 1 |
| Wang, YJ | 1 |
| Hung, SC | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Autoimmune Diabetes
| Article | Year |
|---|---|
Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response.
Topics: Animals; Calcium; Cell Line; Cells, Cultured; Chromones; Diabetes Mellitus, Type 1; Endothelial Cell | 2010 |
Fibronectin and laminin promote differentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERK.
Topics: Blotting, Western; Cell Differentiation; Cell Line; Cell- and Tissue-Based Therapy; Chromones; Diabe | 2010 |